The Journal of Practical Medicine >
Analysis of risk factors associated with kidney injury in early-onset type 2 diabetes mellitus
Received date: 2025-09-27
Online published: 2026-01-14
Objective To identify risk factors associated with renal impairment in early-onset type 2 diabetes mellitus (EOT2DM) through a multidimensional assessment, so as to provide a scientific basis for establishing an early warning system and optimizing clinical intervention strategies. Methods This retrospective study recruited 541 patients diagnosed with EOT2DM who were admitted to the Department of Endocrinology at the Jiangsu Provincial Hospital of Traditional Chinese Medicine from August 2024 to August 2025. The participants were stratified into two groups according to the presence of abnormal renal impairment indicators: an EOT2DM group with renal impairment (n = 241) and an EOT2DM group without renal impairment (n = 300). Clinical data were collected and underwent univariate analysis. Variables with a P-value < 0.05 in the univariate analysis, as well as variables with established clinical significance according to previous literature (even if P ≥ 0.05), were included in a least absolute shrinkage and selection operator (LASSO) logistic regression model to remove redundant variables. Subsequently, multivariate logistic regression analysis was carried out. The optimal cut-off values for significant continuous variables were identified by calculating the Youden's index. Based on these cut-offs, continuous variables were dichotomized into high-risk (≥ cutoff) and low-risk (< cutoff) groups. After covariance adjustment, the adjusted odds ratios (ORs) and their 95% confidence intervals (CIs) were computed to accurately quantify the independent association between the level of each risk variable and the risk of renal impairment in EOT2DM. Receiver Operating Characteristic (ROC) curves were drawn, and the discriminatory ability of each risk factor was evaluated by the area under the ROC curve. Results Multivariate logistic regression analysis has identified six risk factors: sTM (OR = 1.789, AUC = 0.702), TG (OR = 2.647, AUC = 0.602), UA (OR = 1.693, AUC = 0.637), LDL-C (OR = 1.942, AUC = 0.562), WHR (OR = 2.364, AUC = 0.566), and carotid plaque (OR = 1.872, AUC = 0.607). After further refining the strength of the association by using cutoff values, the following four risk factors were determined: sTM, TG, WHR, and carotid plaque. Conclusions Elevated sTM, TG, WHR, and the presence of carotid plaque are independent risk factors for renal impairment in patients with EOT2DM. Among these, sTM demonstrated superior accuracy for renal impairment in EOT2DM and may be more suitable as a clinical assessment tool.
Jia LI , Xinyue LIU , Jia SHI , Xiaoxuan FAN , Su LIU . Analysis of risk factors associated with kidney injury in early-onset type 2 diabetes mellitus[J]. The Journal of Practical Medicine, 2026 , 42(1) : 87 -93 . DOI: 10.3969/j.issn.1006-5725.2026.01.011
| [1] | GENITSARIDI I S P, SALIM A S S F, TOMIC D J S, et al. Idf Diabetes Atlas: Global, Regional and National Diabetes Prevalence Estimates for 2024 and Projections for 2050[J]. SSRN, 2025:1-2.doi: 10.1016/j.diabres.2021.109119 . |
| [2] | International Diabetes Federation. IDF Global Clinical Practice Recommendations for Managing Type 2 Diabetes 2025[J]. Diabetes Res Clin Pract, 2025, 224: 112238. doi: 10.1016/j.diabres.2025.112238 . |
| [3] | 袁慧娟, 杨俊朋, 邓欣如, 等. 成人早发2型糖尿病诊治专家共识[J]. 中华实用诊断与治疗杂志, 2022, 36(12): 1189-1198. doi:10.13507/j.issn.1674-3474.2022.12.001 . |
| [4] | ZHAO M, SONG L, SUN L, et al. Associations of Type 2 Diabetes Onset Age With Cardiovascular Disease and Mortality: The Kailuan Study[J]. Diabetes Care, 2021, 44(6): 1426-1432.doi: 10.2337/dc20-2375 . |
| [5] | MISRA S, KE C, SRINIVASAN S, et al. Current insights and emerging trends in early-onset type 2 diabetes[J]. Lancet Diabetes Endocrinol, 2023, 11(10): 768-782. doi: 10.1016/S2213-8587(23)00225-5 . |
| [6] | WU Y, WANG Y, ZHANG J, et al. Early-onset of type 2 diabetes mellitus is a risk factor for diabetic nephropathy progression: A biopsy-based study[J]. Aging (Albany NY), 2021, 13(6): 8146-8154. doi: 10.18632/aging.202624 . |
| [7] | LIU J J, LIU S, GURUNG R L, et al. Risk of progressive chronic kidney disease in individuals with early-onset type 2 diabetes: A prospective cohort study[J]. Nephrol Dial Transplant, 2020, 35(1): 115-121.doi: 10.1093/ndt/gfy211 . |
| [8] | KE C, SHAH B R, LUK A O, et al. Cardiovascular outcomes trials in type 2 diabetes: Time to include young adults[J]. Diabetes Obes Metab, 2020, 22(1): 3-5. doi: 10.1111/dom.13874 . |
| [9] | SARGEANT J A, BRADY E M, ZACCARDI F, et al. Adults with early-onset type 2 diabetes (aged 18-39 years) are severely underrepresented in diabetes clinical research trials[J]. Diabetologia, 2020, 63(8): 1516-1520. doi: 10.1007/s00125-020-05174-9 . |
| [10] | LASCAR N, BROWN J, PATTISON H, et al. Type 2 diabetes in adolescents and young adults[J]. Lancet Diabetes Endocrinol, 2018, 6(1): 69-80. doi: 10.1016/S2213-8587(17)30186-9 . |
| [11] | NORMAN G, MONTEIRO S, SALAMA S. Sample size calculations: should the emperor's clothes be off the peg or made to measure[J]. BMJ,2012,345: e5278. doi: 10.1136/bmj.e5278 . |
| [12] | JUFAR A H, LANKADEVA Y R, MAY C N, et al. Renal functional reserve: From physiological phenomenon to clinical biomarker and beyond[J]. Am J Physiol Regul Integr Comp Physiol, 2020, 319(6): R690-R702.doi: 10.1152/ajpregu.00237.2020 . |
| [13] | SáNCHEZ-HIDALGO J J, SUáREZ-CUENCA J A, LOZANO-NUEVO J J, et al. Urine transferrin as an early endothelial dysfunction marker in type 2 diabetic patients without nephropathy: A case control study[J]. Diabetol Metab Syndr, 2021, 13(1): 128.doi: 10.1186/s13098-021-00745-1 . |
| [14] | 郝宝顺, 张辉, 刘雪莲, 等. 糖尿病早期肾病患者血管内皮功能的超声研究[J]. 中华临床医师杂志(电子版), 2011, 5(18): 5331-5335. doi: 10.3877/cma.j.issn.1674-0785. 2011. 18.021 . |
| [15] | MAGLIANO D J, SACRE J W, HARDING J L, et al. Young-onset type 2 diabetes mellitus-implications for morbidity and mortality[J]. Nat Rev Endocrinol, 2020, 16(6): 321-331. doi: 10.1038/s41574-020-0334-z . |
| [16] | 刘晓, 白海龙, 边云. 糖尿病肾病患者血栓相关因子动态评估对血栓风险的预测价值[J]. 中国临床研究, 2024, 37(7): 1055-1059.doi: 10.13429/j.cnki.cjcr.2024.07.014 . |
| [17] | LASZIK Z G, ZHOU X J, FERRELL G L, et al. Down-regulation of endothelial expression of endothelial cell protein C receptor and thrombomodulin in coronary atherosclerosis[J]. Am J Pathol, 2001, 159(3): 797-802. doi: 10.1016/S0002-9440(10)61753-1 . |
| [18] | DRO?D? D, ??TKA M, DRO?D? T, et al. Thrombomodulin as a New Marker of Endothelial Dysfunction in Chronic Kidney Disease in Children[J]. Oxid Med Cell Longev, 2018, 2018: 1619293. doi: 10.1155/2018/1619293 . |
| [19] | 张心钰, 田风胜. 纤维蛋白原与糖尿病肾病相关性的研究进展[J]. 中国医药导报, 2023, 20(18): 61-64.doi: 10.20047/j.issn1673-7210.2023.18.13 . |
| [20] | ISERMANN B, VINNIKOV IA, MADHUSUDHAN T, et al. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis[J]. Nat Med, 2007,13(11): 1349-58.doi: 10.1038/nm1667 . |
| [21] | YANG S M, KA S M, WU H L, et al. Thrombomodulin domain 1 ameliorates diabetic nephropathy in mice via anti-NF-κB/NLRP3 inflammasome-mediated inflammation, enhancement of NRF2 antioxidant activity and inhibition of apoptosis[J]. Diabetologia, 2014,57(2): 424-434.doi: 10.1007/s00125-013-3115-6 . |
| [22] | BALDRIGHI M, MALLAT Z, LI X. NLRP3 inflammasome pathways in atherosclerosis[J]. Atherosclerosis, 2017, 267: 127-138. doi: 10.1016/j.atherosclerosis.2017.10.027 . |
| [23] | IWASHIMA Y, SATO T, WATANABE K, et al. Elevation of plasma thrombomodulin level in diabetic patients with early diabetic nephropathy[J]. Diabetes, 1990, 39(8): 983-988. doi: 10.2337/diab.39.8.983 . |
| [24] | LI W, SHENG S, ZHU F. Efficacy and safety of antithrombin or recombinant human thrombomodulin in the treatment of disseminated intravascular coagulation: A systematic review and meta-analysis[J]. Thromb Res, 2025, 249: 109302. doi: 10.1016/j.thromres.2025.109302 . |
| [25] | HUANG Y, FU R, ZHANG J, et al. Dynamic changes in metabolic syndrome components and chronic kidney disease risk: A population-based prospective cohort study[J]. BMC Endocr Disord, 2025, 25(1): 137. doi: 10.1186/s12902-025-01958-5 . |
| [26] | GUAN M, CUI S, SONG H, et al. Association between the triglyceride to high-density lipoprotein cholesterol ratio and diabetes mellitus likelihood in patients with chronic kidney disease[J]. BMC Nephrol, 2025, 26(1): 470. doi: 10.1186/s12882-025-04377-9 . |
| [27] | KEANE W F, TOMASSINI J E, NEFF D R. Lipid abnormalities in patients with chronic kidney disease: Implications for the pathophysiology of atherosclerosis[J]. J Atheroscler Thromb, 2013, 20(2): 123-33. doi: 10.5551/jat.12849 . |
| [28] | GONG L, WANG C, NING G, et al. High concentrations of triglycerides are associated with diabetic kidney disease in new-onset type 2 diabetes in China: Findings from the China Cardiometabolic Disease and Cancer Cohort (4C) Study[J]. Diabetes Obes Metab, 2021, 23(11): 2551-2560. doi: 10.1111/dom. 14502 . |
| [29] | PONTREMOLI R, DESIDERI G, ARCA M, et al. Hypertriglyceridemia is associated with decline of estimated glomerular filtration rate and risk of end-stage kidney disease in a real-word Italian cohort: Evidence from the TG-RENAL Study[J]. Eur J Intern Med, 2023, 111: 90-96. doi: 10.1016/j.ejim.2023.02.019 . |
| [30] | REN L, CUI H, WANG Y, et al. The role of lipotoxicity in kidney disease: From molecular mechanisms to therapeutic prospects[J]. Biomed Pharmacother, 2023, 161: 114465. doi: 10.1016/j.biopha.2023.114465 . |
| [31] | YU H, XIE L F, CHEN K, et al. Initiating Characteristics of Early-onset Type 2 Diabetes Mellitus in Chinese Patients[J]. Chin Med J (Engl), 2016,129(7): 778-784. doi: 10.4103/0366-6999.178959 . |
| [32] | REZAEE A, DARROUDI S, YAVARI A, et al. Novel anthropometric and lipid indices as predictors of chronic kidney disease: Insights from a decade-long cohort study[J]. J Health Popul Nutr, 2025, 44(1): 227. doi: 10.1186/s41043-025-00924-0 . |
| [33] | DI SESSA A, PASSARO A P, COLASANTE A M, et al. Kidney damage predictors in children with metabolically healthy and metabolically unhealthy obesity phenotype[J]. Int J Obes (Lond), 2023, 47(12): 1247-1255. doi: 10.1038/s41366-023-01379-1 . |
| [34] | BJERGFELT S S, S?RENSEN I, HJORTKJ?R H ?, et al. Carotid plaque thickness is increased in chronic kidney disease and associated with carotid and coronary calcification[J]. PLoS One, 2021, 16(11): e0260417. doi: 10.1371/journal.pone.0260417 . |
| [35] | WATRAL J, FORMANOWICZ D, PEREK B, et al. Comprehensive proteomics of monocytes indicates oxidative imbalance functionally related to inflammatory response in chronic kidney disease-related atherosclerosis[J]. Front Mol Biosci, 2024, 11: 1229648. doi: 10.3389/fmolb.2024.1229648 . |
| [36] | WANG L, WANG J, JI J, et al. Associations between inflammatory markers and carotid plaques in CKD: Mediating effects of eGFR-a cross-sectional study[J]. BMC Nephrol, 2024, 25(1): 374. doi: 10.1186/s12882-024-03826-1 . |
| [37] | HIRANO T, SATOH N, KODERA R, et al. Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross-sectional study from a regional diabetes cohort[J]. J Diabetes Investig, 2022, 13(4): 657-667. doi: 10.1111/jdi. 13697 . |
| [38] | HIRANO T. Pathophysiology of Diabetic Dyslipidemia[J]. J Atheroscler Thromb, 2018, 25(9): 771-782. doi: 10.5551/jat.RV17023 . |
| [39] | 叶健华, 赵玉钏. 2型糖尿病缓解标准与治疗策略[J]. 实用医学杂志,2023,39(14):1729-17320. doi: 10.3969/j.issn.1006-5725.2023.14.001 . |
/
| 〈 |
|
〉 |